An FDA lawyer explains enforcement discretion, and ASOP Global warns illegal online sellers can now blend in with compliant ones.
Recap by typeshit. Full story at GQ.
A pharmacist writes that FDA scientists recommended against all seven peptides reviewed, and warns the policy could weaken incentives to run real trials.
The unapproved Lilly drug was confiscated in a dozen enforcement raids, part of a growing crackdown on gray-market retatrutide sellers.
KKM says it has seized 759 units of GLP-1 receptor agonist products worth RM405,170 since 2025 in its crackdown on unlicensed sellers.
Bhekisisa reports South Africa's regulator sees sellers on WhatsApp, Facebook and X. Inspectors close one down and another quickly takes its place.
Sales missed forecasts by about $33 million, but Lilly says demand more than tripled. Novo's Wegovy pill still holds roughly 75% of oral GLP-1 scripts.
A short post says demand for GLP-1s, psychedelics and testosterone is meeting commercial interests, calling it a big shift.
Loading…